Tribio InVivoMAb Anti-hEGFRvIII & mCD3e Bispecific Antibody (TBS10471)

Description

Description: Tribio EGFRvIII & CD3E InVivoMAb Bispecific Antibody targets EGFRvIII on tumor cells and CD3E on T cells, redirecting T cell–mediated cytotoxicity toward EGFRvIII-positive cancer cells. It is commonly used in cancer immunotherapy research, especially in glioblastoma models, to study T cell engagement and tumor killing.

Applications: FuncS

Species reactivity: Human, Mouse

Host species: Mouse

Target: Bispecific, Epidermal growth factor receptor, 2.7.10.1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR, ERBB, ERBB1, HER1, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, Cd3e

Isotype: IgG

Accession/UniProt: P00533 & P22646

Concentration: 3 mg/ml

Purity: >95%

Formulation: Liquid

Storage buffer: 0.01M PBS, pH 7.4

Purification: Protein A/G purified from cell culture supernatant.

Clonality: Monoclonal

Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.

Research use only.

Additional information